Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome

Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Titulaer, M, Maddison, P, Sont, J, Wirtz, P, Hilton-Jones, D, Klooster, R, Potman, M, Willcox, N, Smitt, P, Vincent, A, van der Maarel, S, Lang, B, Verschuuren, J
Μορφή:	Conference item
Έκδοση:	2010

Παρόμοια τεκμήρια

Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.
ανά: Titulaer, M, κ.ά.
Έκδοση: (2011)

Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
ανά: Titulaer, M, κ.ά.
Έκδοση: (2011)

HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
ανά: Wirtz, P, κ.ά.
Έκδοση: (2005)

Myasthenia gravis and Lambert-Eaton myasthenic syndrome
ανά: Palace, J, κ.ά.
Έκδοση: (2004)

Lambert-Eaton myasthenic syndrome and survival in patients with small cell lung carcinoma
ανά: Lang, B, κ.ά.
Έκδοση: (2008)

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
ανά: Maddison, P, κ.ά.
Έκδοση: (2011)

HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.
ανά: Wirtz, P, κ.ά.
Έκδοση: (2003)

Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
ανά: Maddison, P, κ.ά.
Έκδοση: (2001)

Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
ανά: Lang, B, κ.ά.
Έκδοση: (2003)

Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)
ανά: Lang, B, κ.ά.
Έκδοση: (2013)

Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome.
ανά: Squier, M, κ.ά.
Έκδοση: (1991)

Lambert-Eaton myasthenic syndrome: the 60th anniversary of Eaton and Lambert's pioneering article
ανά: Paulo José Lorenzoni, κ.ά.

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
ανά: Lorenzoni, P, κ.ά.
Έκδοση: (2008)

P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
ανά: Wirtz, P, κ.ά.
Έκδοση: (2005)

Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome
ανά: Sumera Bukhari MD, κ.ά.
Έκδοση: (2017-07-01)

Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
ανά: Payne, M, κ.ά.
Έκδοση: (2010)

Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan
ανά: Yutaka Furukawa, κ.ά.
Έκδοση: (2022-09-01)

062 Pembrolizumab induced lambert-eaton myasthenic syndrome
ανά: Rob Zielinski, κ.ά.
Έκδοση: (2021-08-01)

Lambert Eaton myasthenic syndrome and pregnancies with the development of transient myasthenic syndrome in newborn
ανά: N. I. Shcherbakova, κ.ά.
Έκδοση: (2015-02-01)

Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient’s perspective
ανά: Lehnerer, S, κ.ά.
Έκδοση: (2024)

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
ανά: Bain, P, κ.ά.
Έκδοση: (1996)

Autoantibodies in the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS)
ανά: Lang, B
Έκδοση: (2007)

Pseudomyopathic Changes in Needle Electromyography in Lambert-Eaton Myasthenic Syndrome
ανά: Teppei Komatsu, κ.ά.
Έκδοση: (2013-01-01)

Electrophysiological and muscle pathological characteristics of Lambert - Eaton myasthenic syndrome
ανά: SUN Qing, κ.ά.
Έκδοση: (2024-10-01)

Non-paraneoplastic Lambert-Eaton myasthenic syndrome with severe gastrointestinal dysfunction. Case report
ανά: Cruz, M, κ.ά.
Έκδοση: (2005)

Electron microscopic study of skeletal muscle in the Lambert–Eaton myasthenic syndrome
ανά: L. L. Babakova, κ.ά.
Έκδοση: (2015-02-01)

The association between Lambert–Eaton myasthenic syndrome and small cell lung carcinoma
ανά: Briggs SEW, κ.ά.
Έκδοση: (2013-05-01)

Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States
ανά: Scott P. Ginebaugh, κ.ά.
Έκδοση: (2022-05-01)

Atypical Presentation of Seronegative Paraneoplastic Lambert–Eaton Myasthenic Syndrome with Cerebellar Ataxia
ανά: Shalesh Rohatgi, κ.ά.
Έκδοση: (2024-06-01)

Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment
ανά: Pascuzzi RM, κ.ά.
Έκδοση: (2022-12-01)

Non-paraneoplastic Lambert-Eaton myasthenic syndrome: a brief review of 10 cases
ανά: Paulo J. Lorenzoni, κ.ά.
Έκδοση: (2010-12-01)

The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
ανά: Pinto, A, κ.ά.
Έκδοση: (2002)

A prospective study of the incidence of sub-clinical Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer (SCLC)
ανά: Bradbury, P, κ.ά.
Έκδοση: (2004)

A prospective study of the incidence of sub-clinical Lambert-Eaton Myasthenic Syndrome (LEMS) in patients with small cell lung cancer (SCLC).
ανά: Bradbury, P, κ.ά.
Έκδοση: (2004)

Efficacy of durvalumab plus chemotherapy in small-cell lung cancer with Lambert-Eaton myasthenic syndrome
ανά: Naoya Ishibashi, κ.ά.
Έκδοση: (2024-01-01)

Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer
ανά: Yuki Nakatani, κ.ά.
Έκδοση: (2018-12-01)

Truncal Ataxia: An Overlooked Symptom in Patients with Lambert–Eaton Myasthenic Syndrome in the Early Stage
ανά: Betül Özenç, κ.ά.
Έκδοση: (2024-06-01)

Lambert-Eaton myasthenic syndrome against the background of thyroid cancer: a clinical case
ανά: Elena V. Khozhenko, κ.ά.
Έκδοση: (2024-04-01)

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
ανά: Motomura, M, κ.ά.
Έκδοση: (1997)

Update on treatment options for Lambert&ndash;Eaton myasthenic syndrome: focus on use of amifampridine
ανά: Lindquist S, κ.ά.
Έκδοση: (2011-05-01)